CAT
Caterpillar Inc.
CAT has the edge over CVU overall, supported by stronger modeled upside and stronger fundamentals.
CVU
CPI Aerostructures, Inc.
CVU's outlook is improving, though it still trails on the overall score.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CVU Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Healthy |
CVU's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over CVU in the historical PE scenario, which offers more potential upside but is not a forecast.
CVU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.6x | $0.69 | -85% |
| Fair | 4.9x | $1.33 | -71% |
| Forward | 14x | $4.61 | — |
| Current | 17x | $4.61 | — |
| Expensive | 20x | $5.47 | +19% |
Historical ranges are pointers, not guarantees.
CVU's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
CVU Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CVU, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over CVU on earnings, with more consistent year-over-year improvement.
CVU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.34 | +24% |
| Q2 2026 | $0.27 | +$0.33 |
| Q1 2026 | $0.12 | -20% |
| Q4 2025 | -$0.07 | -127% |
| Q3 2025 | -$0.03 | -102% |
| Q2 2025 | -$0.06 | -105% |
| Q1 2025 | $0.15 | -89% |
| Q4 2024 | $0.26 | -81% |
| Q3 2024 | $1.37 | +85% |
CVU has returned to profit: it earned $0.27 per share over the past year, after losing money the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over CVU on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over CVU on profitability, with a higher operating margin.
CVU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $17.6M | +16% |
| Q1 2026 | $17.4M | +13% |
| Q4 2025 | $19.4M | -11% |
| Q3 2025 | $19.3M | -0.8% |
| Q2 2025 | $15.2M | -27% |
| Q1 2025 | $15.4M | -19% |
| Q4 2024 | $21.8M | -7.4% |
| Q3 2024 | $19.4M | -4.8% |
CVU's revenue is recovering but still below its 2021 peak: $18M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 6.8% | +20 points |
| Q1 2026 | 11% | +18 points |
| Q4 2025 | 6.4% | -3.1 points |
| Q3 2025 | 9.1% | +1.5 points |
| Q2 2025 | -13% | -24 points |
| Q1 2025 | -7.7% | -12 points |
| Q4 2024 | 9.5% | +3 points |
| Q3 2024 | 7.6% | +1.9 points |
CVU's operating margin was 6.8% last quarter, up 20 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over CVU on cash generation, producing positive trailing cash flow while its opponent burns cash.
CVU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8.5K | +$591.3K |
| Q1 2026 | -$477.8K | +$2.3M |
| Q4 2025 | -$2.1M | -148% |
| Q3 2025 | $211.1K | -64% |
| Q2 2025 | -$599.8K | +$147.1K |
| Q1 2025 | -$2.8M | -$1.8M |
| Q4 2024 | $4.3M | +42% |
| Q3 2024 | $586.9K | +$655.6K |
CVU's free cash flow was −$2M over the past year, against $2M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over CVU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
CVU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.6K shares |
| 1 year | +2.3% | +294K shares |
| 3 years | +3.3% | +417K shares |
| 5 years | +6.4% | +787K shares |
| Available history | +10% | +1.2M shares |
CVU has 13M diluted shares, up 2.3% from a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over CVU on leverage, with a lower net debt burden relative to earnings.
CVU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | -3.7x | Net Cash |
| Q3 2025 | 14.7x | High |
| Q2 2025 | 19.6x | High |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | -0.8x | Net Cash |
| Q3 2024 | 2.5x | Moderate |
CVU's net debt is about 1.3 years of its operating earnings (EBITDA), down from 20 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CVU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.8 | Neutral |
| Stochastic | 17.2 | Oversold |
CVU's weekly RSI is 46 (neutral) and its Stochastic is 17 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CVU PE vs Industrials Sector
| Metric | CVU | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 29% below |
| PE % | 69 | 58 | 11 pts above |
CVU has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
CVU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.90 | 5.9% below |
| 20 week MA | $5.06 | 8.9% below |
| 50 week MA | $4.47 | 3.1% above |
| 100 week MA | $3.89 | 19% above |
| 200 week MA | $3.50 | 32% above |
CVU has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
CVU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.59 | $3.90 | -41% |
| 2021 | $3.90 | $2.28 | -42% |
| 2022 | $2.28 | $3.25 | +43% |
| 2023 | $3.25 | $2.73 | -16% |
| 2024 | $2.73 | $3.93 | +44% |
| 2025 | $3.93 | $3.75 | -4.6% |
| 2026 YTD | $3.75 | $4.61 | +23% |
CVU has the edge over CAT on returns for 2026, with the stronger performance.